Janney Montgomery Scott
DMK

Janney Montgomery Scott’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Janney Montgomery Scott’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-143
Closed -$1K – 2761
2023
Q1 		$1K Hold
143
– – ﹤0.01% 2452
2022
Q4 		$2K Hold
143
– – ﹤0.01% 2556
2022
Q3 		$2K Buy
+143
New +$3.69K ﹤0.01% 2489

Other funds holding DMK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Janney Montgomery Scott's DMK Position: Q2 2023 in Review

Janney Montgomery Scott sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 143 shares — an estimated $1K sold.

Janney Montgomery Scott first reported a position in DMK in Q3 2022 and held it in 3 quarters. The position peaked at $2K in Q4 2022. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

  • Janney Montgomery Scott reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
  • Janney Montgomery Scott sold 143 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $1K.
  • Janney Montgomery Scott first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2022 and held it in 3 quarters.
  • Janney Montgomery Scott's DMK Pharmaceuticals Corporation Common Stock position peaked at $2K in Q4 2022.
  • 22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on Janney Montgomery Scott's 13F filing for Q2 2023, filed 26 Jul 2023.